News

FLAGSTAFF, Ariz. (August 25, 2020) — W. L. Gore & Associates is marking the 20th anniversary of the only covered stent indicated for transjugular intrahepatic portosystemic shunt procedures (TIPS). The GORE^® VIATORR^® TIPS Endoprosthesis, marketed since 2000, and GORE^® VIATORR^® TIPS Endoprosthesis with Controlled Expansion, introduced in 2016, have helped physicians in more than 60 countries to increase survival and improve quality of life in high-risk bleeding and refractory ascites patients.

As the world moves forward shaped by the COVID-19 pandemic, so many of us crave a “return to normal.” At Gore, we too are eager for our Associates to rejoin their colleagues who have remained in our plants to produce essential materials and products.

W. L. Gore & Associates, Inc. (Gore) congratulates the REVISE research team for receiving the JVIR Editor’s Award for Outstanding Clinical Research Paper for 2019 from the Journal of Vascular and Interventional Radiology.

FLAGSTAFF, Ariz. (December 11, 2013) — W. L. Gore & Associates (Gore) today announced that the Food and Drug Administration (FDA) has granted indication for the GORE® VIABAHN® Endoprosthesis to treat stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous access (AV access) grafts.